Article
Design and Synthesis of Glycoside Inhibitors of Glioma and Melanoma Growth
Instituto de Química Orgánica General, CSIC.
Instituto Cajal, CSIC.
Hospital Nacional de Parapléjicos, SESCAM.
Laboratorios FAES FARMA, SA.
To whom correspondence should be addressed. A.F.-M.: phone, 34 91 562 29 00; fax, 34 91 564 48 53; e-mail, mayoralas@iqog.csic.es. M.N.-S.: phone, 34 91 585 47 20; fax, 34 91 585 47 54; e-mail, mns@cajal.csic.es
Abstract

An N-acetylglucosaminide derivative with a pentaerythritol substituent at position C-6 was previously synthesized and shown to inhibit neural tumor growth. Now, we report the preparation of a series of new synthetic compounds introducing systematic changes in the nature, polarity, and size of the sugar substituents. The antimitotic activity of the new compounds was tested on cultured rat (C6) and human (U-373) glioma lines and on a human melanoma line (A-375). The antimitotic and antitumoral activity of the new compounds on glioma cell lines increased up to 2 orders of magnitude with respect to the parent compound or was abolished, permitting a detailed structure−function analysis of the new antitumorals. One of the glycosides inhibited melanoma division with an ID50 below the micromolar range.
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue January 25, 2007
- Received October 5, 2006
Cart



